Skip to content
Home/Companies/HealthTech/BioMAX

BioMAX

HealthTech·Germany·Exited 2022·Held 6yr
Entry
2016
Hold
6yr
Exit
2022

Who owns BioMAX?

BioMAX was owned by Sobera Capital through S-Refit AG (2016 vintage) from 2016 to 2022.

Hand-verified · updated 2026-08-10

Sobera Capital
Investor
Sobera Capital
S-Refit AG · 2016 · Secondaries

Key facts

HQGermany
SectorHealthTech
StatusAcquired
Exit Type
–
Buyer
–
MOIC
–
Exit Year
2022

More from S-Refit AG

Other portfolio companies in the same fund.

Amicra
Exited 2018
Deep TechGermany· 2016
to
Curadis
Active
BiotechGermany· 2016
EnOcean
EnOcean
Exited 2024
Deep TechGermany· 2016
ERS electronic
Exited 2023
IndustrialsGermany· 2016
to
Isarna
Isarna
Active
BiotechGermany· 2016
knowis
knowis
Active
SoftwareGermany· 2016

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
Akrivia Health
Akrivia Health
Active
Future Planet CapitalUK
Paladin
Paladin
Active
Ring CapitalFrance
Access Infinity
Active
CBPE CapitalUK· 2026
Auryx
Active
VentoUnited Kingdom· 2026
Axomove
Axomove
Active
INCO VENTURESFrance· 2026
Track BioMAX

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on BioMAX.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue